The use of [18F]- and [68Ga]-labeled inhibitors of prostate-specific membrane antigen (PSMA) for positron emission tomography (PET) imaging of prostate cancer is now widespread. We have proposed a reporting and data system called PSMA-RADS version 1.0, which is a framework for classifying PSMA-targeted PET scans and individual findings into categories that reflect the likelihood of the presence of prostate cancer.

中文翻译：

---

PSMA-RADS版本1.0：迈向以PSMA为目标的PET成像研究的解释和报告标准化的步骤。

[18F]和[68Ga]标记的前列腺特异性膜抗原（PSMA）抑制剂在前列腺癌的正电子发射断层扫描（PET）成像中的应用现已广泛。我们已经提出了一个称为PSMA-RADS 1.0版的报告和数据系统，该系统是用于将针对PSMA的PET扫描和个人发现分类为反映前列腺癌存在可能性的类别的框架。